Related Experiment Video
Updated: Jul 16, 2026
06:57
In Vivo Infection with Leishmania amazonensis to Evaluate Parasite Virulence in Mice
Published on: February 20, 2020
Cutaneous Leishmania infection: progress in pathogenesis research and experimental therapy
1Department of Dermatology, Johannes Gutenberg-University Mainz, Mainz, Germany. vonstebu@mail.uni-mainz.de
Experimental Dermatology
|March 16, 2007
Summary
Dendritic cells (DCs) are crucial for developing T helper 1 (Th1) immunity against Leishmania major. Understanding DC functions, like Fc gamma receptor-mediated uptake and cytokine production, informs the development of effective leishmaniasis vaccines and treatments.
Area of Science:
- Immunology
- Parasitology
- Vaccinology
Background:
- Murine models of Leishmania major infection reveal key factors for protective T helper 1 (Th1)/cytotoxic T 1 (Tc1) responses.
- Dendritic cells (DCs) play a pivotal role in initiating and shaping adaptive immunity against Leishmania parasites.
Purpose of the Study:
- To review recent advances in understanding the role of DCs in inducing Th1/Tc1-predominant immunity against Leishmania major.
- To explore how this knowledge can be translated into clinical strategies for leishmaniasis prevention and treatment.
Main Methods:
- Review of existing literature on DC function in Leishmania major infection models.
- Analysis of the mechanisms of DC-mediated antigen presentation and T-cell education.
- Evaluation of DC-based vaccine strategies and their potential in combination therapies.
Main Results:
- Fc gamma receptor (Fc gamma R)I and Fc gamma RIII-mediated uptake of Leishmania major amastigotes by DCs is essential for Th1 development.
- DC-derived cytokines are critical for effective T-cell education and the establishment of protective immunity.
- DC-based vaccines show promise for prophylactic use and for modulating immune responses in non-healing leishmaniasis.
Conclusions:
- Dendritic cells are central to orchestrating protective immunity against Leishmania major.
- Targeting DC functions offers a promising avenue for developing novel vaccines and therapeutic strategies for leishmaniasis.
- Further research into DC biology and vaccine applications is warranted for clinical translation.
Related Concept Videos
01:30Leishmaniasis
Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...
01:21Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...
01:22American Trypanosomiasis
Chagas disease, or American trypanosomiasis, is a vector-borne parasitic infection caused by Trypanosoma cruzi, a flagellated protozoan (kinetoplastid) of the family Trypanosomatidae. The disease is endemic in Latin America, although cases are increasingly reported worldwide due to human migration. Transmission most commonly occurs when feces of infected triatomine bugs contaminate bite wounds or mucosal surfaces; additional routes include congenital, transfusional, transplant-related, and oral...